Clinical data | |
---|---|
Drug class | Progestin; Progestogen |
Identifiers | |
CAS Number | |
PubChem SID |
ORG-201745 is a progestin which was originated by Organon and was under development by Schering-Plough (which acquired Organon in 2007) for the treatment of "female genital diseases" and as a hormonal contraceptive for the prevention of pregnancy but was never marketed.
References
- "ORG 201745 - AdisInsight". adisinsight.springer.com.
This drug article relating to the genito-urinary system is a stub. You can help Misplaced Pages by expanding it. |